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Purpose: Chronic inflammatory disorders of the oral cavity, such as periodontitis were recently linked 
to the systemic immune activation. Since fungal oral infections were not studied in this respect yet, 
the aim of our study was to determine whether the local inflammation caused by oral fungal 
infection of the palatal tissue (denture stomatitis – DS), is associated with the systemic inflammatory 
response. This problem is becoming essential in relation to ageing of population.  
Materials and Methods: Peripheral blood of DS patients (n = 20) and control patients (n = 24) was 
assessed with flow cytometry to determine lymphocytes and monocytes profile. Intracellular 
cytometric analysis was carried out to establish cytokine production by T cells. DS was diagnosed 
based on clinical symptoms of DS such as swelling and redness of oral mucosa, confirmed by 
microbiological swabs for fungal colonization with Candida species. Control group was recruited from 
complete-denture users without clinical and microbiological signs of oral infections.  
Results: Percentages of peripheral lymphocytes, T cells, monocytes and their subpopulations were 
similar in both studied groups. The exception was median percentages of CD25+ T cell subsets, which 
were significantly lower in DS patients than in control subjects. This reduction was observed in both 
CD4 T cell subset (16.7% and 28.1%; p = 0.0006) and CD8 T cells (4.6% and 7.0%; p = 0.007) 
Conclusions: While DS and associated local fungal infection does not overtly affect activation of 
monocytes or lymphocytes, the number of CD 25+ T cells is significantly lower in the DS patients, 
possibly indicating limited potential for the infection clearance in denture using ageing subjects.  
 
KEYWORDS: systemic inflammation, Candida albicans, denture stomatitis, lymphocytes, monocytes, 
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CCR5 - C-C chemokine receptor type 5 
CD - cluster of differentiation 
DS - denture-related stomatitis 
FSC - forward-scattered light channel 
HLA - human leukocyte antigens 
IFN - interferon 
IL - interleukin 
PBMC – peripheral blood mononuclear cells 
RANTES - Regulated on Activation, Normal T-cell Expressed and Secreted chemokine 
SD - standard deviation 
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SSC - side-scattered light channel 
Th - T helper cells 
TNF - Tumour Necrosis Factor 
Treg - regulatory T cells 




Denture stomatitis is an important clinical problem affecting quality of patients' life and, as recently 
indicated, may co-incide with selected systemic co-morbidities including vascular dysfunction1. The 
mechanisms of these co-morbidities are unclear, mainly because it is not clear to which extent 
immunopathogenic process in the oral cavity of patients with denture stomatitis affects systemic 
immunity.  
Recent years have brought better understanding of the importance of chronic, low-grade 
inflammation in mediating the risk of cardiovascular diseases, cancer as well as rheumatoid 
disorders. Oral cavity, which is inhabited by 500 different species of microorganisms forming biofilm, 
is a very important potential site of initiation and propagation of such low-grade inflammation. While 
numerous studies have focused on the role of periodontitis or periapical changes as sites of origin of 
low grade inflammation2, recent studies have suggested that denture stomatitis might also represent 
such chronic low grade inflammation.  
The systemic characteristics of T cells or monocytes in denture stomatitis (DS) have not been 
described. DS is a fungal infection, most commonly with Candida species. They are part of 
commensal flora of the oral cavity, however the combination of denture presence together with 
factors such as: low salivary pH, high sugar consumption3 or low saliva flow contribute to excessive 
fungal growth. Mucosal immune response to fungal pathogens include neutrophils as major effectors 
of the innate response, driven by cytokines released from epithelial cells after contact with 
pathogen4,5.  However, epithelial cells produce also β-defensin 2 and CCL20 orchestrating dendritic 
cell recruitment6 which present fungal antigens to the T cell. It was long thought, that Th1 are the 
leading type of response for fungal infection, but after discovering the existence of IL-17 producing 
Th17 cells, this type of immune reaction appears to be vital7, with suppressive T regulatory (Treg) 
cells playing role in counter-balancing the Th17 response6. Mice lacking IL-17 signalling (IL-23-/- or IL-
17A receptor-/-) are more susceptible for oral candidiasis than wild-type mice8. Similarly, in humans 
genetic variations of IL-17 related genes are associated with increased susceptibility9–12, to chronic 
mucocutaneous candidiasis. It remains unclear, how are these local immune responses reflected by 
the changes in systemic immunity and subpopulations of proinflammatory T cells and monocytes in 
peripheral blood of DS patients. There are limited studies suggesting that oral candidal infection may 
impact peripheral blood mononuclear cells and cytokine production in vitro in response to Candida 
antigens13,14 is altered, although it is not clear which type of the cells: monocytes or lymphocytes 
primarily response.   
Therefore, the aim of our study was to determine whether the local inflammation caused by 
presence of denture-related stomatitis, coincides with the systemic inflammatory response, depicted 
as activation of peripheral blood immune cells 
 
Methods  
Patients and clinical evaluation: Consecutive patients using dental prostheses for at least 6 months 
were recruited to the study and assigned to two groups: DS patients (n = 20), and control non-DS (n = 
24) subjects, who presented with healthy oral mucosa1.  
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Detailed methodology, clinical data acquisition and exclusion criteria along with major systemic 
clinical features were described previously1. In brief, patients' oral mucosa was examined to detect 
the presence of clinical symptoms of DS such as: erythema, swelling. Additionally, patients’ 
subjective complains, such as such as discomfort and pain in the palatal area were registered. The 
swabs from the inflamed area have been taken for the routine microbiological laboratory diagnostic 
tests for Candida species presence to confirm clinical diagnosis. Swabs were taken from the hard 
palate (between the second and third palatal fold). Samples were collected after an overnight fast 
and after at least 6 hours of continuous denture usage, without the use of adhesives or rinsing the 
mouth with disinfectants. Samples were collected by gently rubbing a sterile cotton swab moist with 
saline over the palatal tissue and then subsequently inoculating a primary isolation in dextrose agar 
transport medium. The collected sample was transported to the laboratory immediately after 
patients’ visit.  Candida identification was made according to the colour of the colony on CHROMagar 
Candida medium (Graso Biotech, Starogard Gdański, Poland) after 36 to 48 hours of incubation in 
36°C. Patients were recruited to DRS group when clinical symptoms were confirmed by positive 
microbiological culture of Candida species from the palatal tissue. In patients with some teeth 
present, the periodontal examination was carried out to exclude patients with periodontitis (one or 
more periodontal pocket depth ≥4 mm). Exclusion criteria also included: acute inflammatory 
disorders and chronic inflammation other than DS, neoplastic disease and relapses and 
chemotherapy courses less than 5 years before the enrolment, antibiotics usage in less than 4 weeks 
or anti-inflammatory drugs regiment (steroids and non-steroidal, excluding aspirin in doses less than 
80 mg) in less than 2 months before the enrolment. Patients with history of myocardial infarction, 
acute coronary incident or vascular inflammation in 5 weeks or less before the enrolment, chronic 
haematological disorders and immunodeficiency or major medication changes during less than 5 
weeks before or during study were also excluded.  
The study was independently reviewed and approved by local ethics committee of Jagiellonian 
University, Cracow, Poland. Written informed consent was obtained from all patients and study was 
conducted in accordance with the Declaration of Helsinki. This study has been registered in 
ClinicalTrials.gov (identification no. NCT02166450). Information about systemic risk factors of DS 
such as diabetes (fasting glucose level ≥7 mmol/L or HbA1c >6.5% or current treatment with insulin 
or oral hypoglycaemic agents), and smoking (current or within last 6 months) were based on patient 
medical records and detailed patient history. Definition of clinical risk factors was based on European 
Guidelines on cardiovascular disease prevention in clinical practice from 201215. 
Extracellular cytometric analysis: Blood samples were collected in ethylenediaminetetraacetic acid-
containing tubes (Becton Dickinson (BD), Franklin Lakes, NJ, USA). PBMC were isolated using 
Lymphocyte Separation Medium LSM 1077 (PAA Laboratories GmbH, Pasching, Austria). After 
isolation, cells were washed twice with phosphate-buffered saline with heat inactivated 1% fetal 
bovine serum (Gibco, Life Technologies, Carlsbad, CA, USA) and then incubated for 20 minutes at 4°C 
with fluorescently labelled monoclonal antibodies (all antibodies were purchased from BD 
Pharmingen, San Diego, CA, USA). After washing, cells were re-suspended in phosphate-buffered 
saline with 1% fetal bovine serum (Gibco, Life Technologies, Carlsbad, CA, USA) and studied on a 
FACSCanto II or FACSVerse cytometer (BD Bioscences, San Jose, CA, USA). Results were analyzed 
using FlowJo vX software (FLOWJO LCC Data Analysis Software, Ashland, OR, USA). Lymphocytes 
were identified in PBMC on forward-scattered light channel (FSC)/ side-scattered light channel (SSC) 
scatter plots and T cell presence was confirmed by CD3 staining. Percentages of naive (CD45RA+) and 
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memory (CD45RO+) and CD4+ and CD8+ T cells were assessed, as well as presence of surface 
activation markers in these subpopulations. Monocytes were also identified on FSC/SSC scatter plots 
with confirmation of CD14/human leukocyte antigens (HLA)-DR staining. Three main populations 
were assessed among monocytes: CD14highCD16-, CD14dimCD16+ and CD14highCD16+. Both gating 
strategies are presented on Figures 1b and 5b. The following monoclonal antibodies were used: anti-
CD3-PerCP (clone SK7), anti-CD45RA/CD45RO/CD3/CD4 BD Multitest™, anti-CD4-APC (clone RPA-T4), 
anti-CD4-PeCy7 (clone SK3), anti-CD8-APCH7 (clone SK1), anti-CCR7-PECy7 (clone 3D12), anti-C-C 
chemokine receptor type 5 (CCR5)-PE (2D7/CCR5), anti-CD69-FITC (clone FN50), anti-CD25-PE (clone 
MA-251), anti-CD28-APC (clone CD28.2), anti-CD14-APCH7 (clone MⱷP9), anti-HLA-DR-PeCy7 (clone 
L243), anti-CD16-PE (clone 3G8). Because of technical reasons, it was impossible to perform 
monocyte analysis in one patient in DS group. 
Intracellular cytometric analysis: Cytokine production by T cells was assessed after 4-hour 
incubation of PBMC in Roswell Park Memorial Institute medium 1640 (Gibco, Life Technologies, 
Carlsbad, CA, USA) with 10% fetal bovine serum (Gibco, Life Technologies, Carlsbad, CA, USA), 
gentamycin and L-glutamine (Sigma, Saint Louis, MO, USA) with stimulation with Leukocyte 
Activation Cocktail with BD GolgiPlug (BD Pharmingen, San Diego, CA, USA). After 20 minutes of on 
ice staining for cell surface markers (CD3, CD4 and CD8; procedure, suppliers and clones as presented 
above), cells were washed with phosphate-buffered saline with heat inactivated 1% fetal bovine 
serum (Gibco, Life Technologies, Carlsbad, CA, USA). Cells were permeabilized (20 minutes, on ice) 
(BD Cytofix/Cytoperm, Fixation and Permeabilization Solution, BD Pharmingen, San Diego, CA, USA) 
and, after washing with BD PermWash Buffer (BD Pharmingen, San Diego, CA, USA), stained for 
intracellular cytokines for 20 minutes, on ice. Then the cells were washed again with BD PermWash 
Buffer (BD Pharmingen, San Diego, CA, USA), resuspended in phosphate-buffered saline with 1% fetal 
bovine serum (Gibco, Life Technologies, Carlsbad, CA, USA) and studied by flow cytometry, as 
described for extracellular staining procedure. The following monoclonal antibodies were used: anti-
IL-17-PE (clone N49-653), anti-IL-4-PE (clone 8D4-8), anti-TNFα-FITC (clone MAb11) and anti-IFNγ-
FITC (clone B27). Non-specific staining with isotype-matched control monoclonal antibodies was used 
(PE Mouse IgG1κ Isotype Control, clone MOPC-21 and FITC Mouse IgG1κ Isotype Control, clone 
MOPC-21). All antibodies were from BD Pharmingen, San Diego, CA, USA. 
Statistical analysis: Assessment of normality of distribution for all continuous variables was 
conducted by Shapiro-Wilk test. Variables whose distributions were not consistent with a normal 
distribution are presented as median and 25th (Q1); 75th (Q3) percentiles and tested by Mann-
Whitney U test. Variables with normal distribution are presented as mean with standard deviation 
(SD) and tested with Student's t test. Dichotomous variables were tested by Chi2 test for the 
expected frequencies equal or higher than 5. If the expected frequencies were lower than 5, Yates' 
correction was applied, and Fisher's Exact test was executed for confirmation. Values of p < 0,05 
were considered statistically significant. All analyses were performed with Statsoft Statistica software 
(StatSoft, Inc., Tulsa, OK, USA). 
 
Results 
Patient characteristics: DS and non-DS groups were comparable in relation to age (mean±SD 64±7 
and 66±10, respectively) and gender (2M/18F and 6M/18F, respectively) and major clinical 
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characteristics (Table 1). Compared to the general population, the proportion of females was higher 
in both groups of subjects using dental prostheses. Proportions of smokers (30% and 12,5%) and 
diabetic patients (30% and 8,3%) were higher in DS group, as these factors are key risk factors for DS, 
but the difference did not reach statistical significance. Clinical description of DS and control group 
patients is presented in Table 1.  Detailed characteristics describing cardiovascular status of study 
groups patients was published in the previous article1. Most of the screened subjects were 
edentulous (n = 36). 
 
Lymphocyte characterization in peripheral blood of DS patients: Percentages of total lymphocytes 
and T cells in peripheral blood mononuclear cell (PBMC) of DS and control patients has shown no 
significant differences (Figure 1a upper panel). Similarly no differences were observed in CD4+ and 
CD8+ T cell subsets (Figure 1a lower panel). Further studies have shown that presence of DS did not 
seem to affect median percentages of naive (CD45RA+; 47.15 (31.80; 57.0) and 37.5 (31.55; 49.65); 
p = 0.25) and memory (CD45RO+; 43.15 (31.55; 55.65) and 49.35 (40.25; 57.40); p = 0.24) T cells. 
Percentages of the naive (CD45RA+CCR7+), effector (CD45RA-CCR7-) and memory (CD45RA-CCR7+) T 
cells from both, CD4+ and CD8+ populations, also did not show any differences between the groups 
(Figure 2a,b). 
Lymphocyte activation in peripheral blood of DS patients: Interestingly, we found that the median 
percentages of cells expressing late activation marker CD25 from CD4+ and CD8+ subsets were 
significantly lower in the DS group (p = 0.0006 and 0.0076, respectively), but there were no 
differences between the groups in percentages of CD4+ and CD8+ expressing early activation marker 
CD69 (Figure 3a). Percentages of CD4+ and CD8+ CD28null subsets were also similar in both groups 
(Figure 3a). Median percentages of CD4+CCR5+ T cells in DS and control group were 4.26 (3.41; 5.19) 
and 4.65 (3.58; 11.3), and CD8+CCR5+ 15.10 (8.92; 18.15) and 20.65 (10.69; 35.90), respectively 
(Figure 3a). These differences were not statistically significant.  
CD25high T regulatory cells in DS: As CD25+ cells represent both late activation marker bearing cells, 
as well as T regulatory, suppressive cells, we next investigated the characteristics of CD25+ cells 
taking into account, that CD25high T cells represent typically the naturally occurring regulatory T cells 
in humans16 (Figure 3c). Consequently, the percentage of CD25high cells was lower in DS patients 
than in controls in CD4+ T cell subset (Figure 3b). However, the difference in CD25high cells was not 
significant in CD8+ T cells. 
T cell cytokine production in DS: We next performed intracellular staining to investigate major 
proinflammatory cytokine production in peripheral blood T cells in DS. There was no significant 
difference in IL-17, IFN-γ and TNF-α production between healthy and DS group. Additionally, we did 
not see the difference in IL-4 cytokine production (Figure 4). 
Monocyte characteristics in the peripheral blood of DS patients: As peripheral blood monocyte 
subpopulation changes might also reflect systemic chronic inflammation, we next analysed monocyte 
subsets based on CD14+ and CD16+ expression. We found that there were no statistically significant 
differences in percentage of monocytes present in the peripheral blood of both groups, as well as in 
percentages of three subsets of these cells: CD14highCD16-, CD14highCD16+ and CD14dimCD16+ 





Denture-related stomatitis is an inflammatory process of the oral mucosa with increasing importance 
in the ageing of populations, as it is one of the most common diseases among elderly denture 
wearers17,18. It affects around 15 - 70% of subjects older than 65 and is most common in complete 
prosthesis users17–19. The prevalence range described in the literature is wide, most probably because 
of different population samples investigated in different studies, but generally it appears to be more 
common in women17, diabetic and smoking patients20.  
Systemic nature of immune activation in condition of fungal infection of the palatal tissue described 
as DS is still unclear. According to our hypothesis, that presence of DS in oral cavity might lead to the 
chronic, low grade systemic inflammation caused by persistent fungal infection. However, we did not 
observe in our study any relationship between presence of this condition and the percentage of 
lymphocytes and T cells present in the peripheral blood. The same observation was also true for 
CD4+ and CD8+ T cell subsets. Lack of differences in CD4+ T cell subsets was the most surprising as 
this lymphocyte subset is thought to be of great importance in Candida immunity21. However, in our 
study group the fungal infection was connected with exogenous (denture), not an endogenous 
(immunosuppression caused by a viral pathogen) factor, thus the immune response may have 
different characteristics. Naive (CD45RA+), memory (CD45RO+) and CD28null T cells subsets were 
studied, because DS is frequently asymptomatic and can persist untreated for long periods of time 
and persistent infection provoking continuous immune activation may accelerate senescence of 
CD8+ T cells marked by loss of CD28 marker22. CCR5 gene expression was shown to be enhanced in 
peripheral blood monocytes stimulated with C. albicans in vitro23, and PBMC were shown to secrete 
RANTES in response to C. albicans presence24, therefore we studied expression of chemokine RANTES 
receptor CCR5 on T cells. Groups did not differ regarding to none of these cell subpopulations, 
probably reflecting predominantly local nature of inflammatory response in the oral mucosa in DS, 
which was clinically evident. We also compared amount of monocytes and their subpopulations 
between groups, as these cells and their differentiated form - macrophages are elements of the first 
line of immunologic defence against invading pathogen. Similarly, local inflammation on the oral 
mucosa in DS was not associated with changes of monocyte subsets. However, monocytes are very 
well known to play important role in inflammatory diseases such as rheumatoid arthritis or 
atherosclerosis25,26. It appears that especially CD16+ subsets are vital and their role in inflammatory 
conditions were described previously in end stage renal disease and in active rheumatoid 
arthritis25,27. Changes in monocyte subpopulations are visible even at very early stage of disease28, 
with increased amount of intermediate CD14highCD16+ and decreased amount of non-classical 
(CD14dimCD16+) monocytes. 
In summary, lack of differences in peripheral blood immune cell subtypes may point to the lack of 
systemic response to oral C. albicans infection. While this is in contrary to our hypothesis, we believe 
that this is a very important consideration for interpretation of some of systemic features of DS.  
While no differences were identified by our study in relation to naïve, effector or other T cell or pro-
inflammatory monocyte subsets, we observed a lower occurrence of T cells positive for late 
activation marker, namely CD25, in the peripheral blood of DS patients. While CD25 is classically 
induced by activation, it is also characteristic for naturally occurring T regulatory cells29, which are 
characterized by a particularly high expression of CD25 (CD4+CD25high). While we have not studied 
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transcription factor characteristic for Tregs - FoxP3, our preliminary experiments showed, that 
CD4+CD25high T cells express FoxP3 in peripheral blood in humans. Treg cells have a suppressive 
effect in relation to the immune system, which, under physiological conditions, is very important for 
the proper regulation of immune response29. In that regard, lower levels in DS patients could seem 
counterintuitive or indicate their exit to inflamed tissues and lower ability towards resolution of 
chronic inflammation, which could promote DS. Importance of T regulatory cells has, however, been 
recently emphasized in immune response to candidosis, during which their predominant function 
seems to be related to promoting pro-inflammatory Th17 type immune response, while suppressing 
other arms of immune response, which is vital for clearance of fungal infections30. It is also known, 
that patients with low number of functional Treg cells, known as IPEX (Immune Dysregulation, 
Polyendocrinopathy, Enteropathy, X-linked) caused by mutations in the FoxP3 gene are susceptible 
to infections, including Candida31. 
Finally, decreased CD4+CD25high T cells could provide a link between chronic oral inflammation in 
DS and risk factors such as diabetes. Indeed, diabetic subjects were overrepresented in DS study 
group, and presence of this condition is associated with lower numbers of CD25+ T cells32. These 
results may suggest that lower CD4+CD25+ T cells in DS could link mechanistically these two 
conditions, although subsequent studies characterizing these mechanisms are warranted. Thus, 
unexpectedly, our results may point our attention towards a possible mechanism of chronic 
inflammation in DS patients rather, than showing systemic consequences of this process.  
Our study has some limitations - all of the experiments were performed in a relatively small number 
of patients and, as such, should be considered preliminary, although up to date no other study has 
systematically addressed the issue of peripheral T cell and monocyte activation in relation to DS. It 
should be also kept in mind, that presence of confounders, such as diabetes mellitus or smoking, 
although not statistically significant, can affect the results. While studied group is insufficient to 
control for these factors statistically, we should bear in mind that these are genuine and strong risk 
factors of the disease, so lack of difference between groups would render this comparison clinically 
less meaningful. The caution is also needed also to make wide conclusion on general population, as 
predominance of women in both study groups was obvious, although again linked to DS 
epidemiology. Finally, while cytometric methods used in the present study are considered sensitive 
and accurate, their sensitivity may not be sufficient to detect extremely subtle differences in markers 
and mediators33. However, such differences would be unlikely to have clinical relevance.  
In summary, although immune mechanisms involved in the local immune defence against oral fungal 
infection are very complex and include various cell types - not only immune cells4,21,34, but also 
epithelial cells of the infected tissues35, the main observation of our work is the lack of the evidence 
of systemic cellular response to oral C. albicans infection. At the same time, differences regarding 
CD4+CD25high+ T cell subsets may point to the potential role of Treg cells in susceptibility of diabetic 
patients to denture-related stomatitis. Knowledge of the detailed mechanism responsible for 
increasing DS risk in diabetics may allow for an effective prevention of oral fungal infections in this 
population, thus improving comfort of denture usage and patient's quality of life. Prevention of DS 
might also be of particular importance, in the light of our previous work, where higher prevalence of 
endothelial dysfunction in DS patients was observed1. Endothelial dysfunction as a symptom 
preceding the development of atherosclerosis36, may have serious consequences for the health and 
life of the patients. Therefore, reducing the risk of its occurrence constitutes an important clinical 
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goal. Growing body of evidence suggests, that Th17 immune response, plays an important role in 
immune responses to mucosal and cutaneous candidosis37. Recently discovered role of these 
proinflammatory mechanisms in hypertension38,39 makes these immune cells a particularly interesting 
target for research looking into the mechanisms linking oral  and cardiovascular disease.  
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Table 1. Studied groups clinical characteristics. Data are presented as mean (SD) or n (%). 
 DS patients Control group P value 
Number of patients 20 24  
Age [years] 63.9 (6.6) 65.9 (10.3) 0.425 
BMI 29.7 (5.8) 27.9 (5.3) 0.297 
Gender (M:F) 2 : 18 6 : 18 0.259 
Partial upper denture 5 (25%) 3 (12.5%) 0.436 
Complete upper dentures 15 (75%) 21 (87.5%) 0.436 
Current smoking 6 (30%) 3 (12.5%) 0.261 
Smoking in the past 2 (10%) 10 (41.7%) 0.083 
Diabetes 6 (30%) 2 (8.3%) 0.115 
Coronary artery disease 9 (45%) 8 (33.3%) 0.631 
Controlled hypertension 8 (40%) 10 (41.7%) 0.845 
Untreated hypertension 9 (45%) 10 (41.7%) 0.934 





















Figure 5. Maciąg et al 
20 
 
Figure legends:  
Figure 1. (a) Lymphocytes and their basic subpopulations in DS and control patients. Comparison of 
lymphocytes and T cells counts and basic T cell subpopulations: CD4+ and CD8+ in control and DS 
patients. Lymphocyte subpopulation was measured in peripheral blood by flow cytometry. Results 
presented as median (Q1; Q2). (b) Example of flow cytometric gating strategy in PBMC. Gating of 
lymphocytes and their subsets: G1 - PBMC, L1 - lymphocytes, M1 - monocytes, L2 - T cells, L3 - CD8+ 
T cells, L4 - CD4+ T cells.  
Figure 2. (a) Subsets of the naive, effector and memory CD4+ and CD8+ T cells present in peripheral 
blood of DS and control patients. Counts of the naive (CD45RA+CCR7+), effector (CD45RA-CCR7-) 
and memory (CD45RA-CCR7+) T cells were assessed by flow cytometry. Results presented as median 
(Q1; Q2). (b) Example of flow cytometric results and gating strategy for naive, effector and memory 
CD4+ (upper panel) and CD8+ (lower panel) subsets. 
Figure 3. (a) Comparison of percentage of activated T cells and CCR5+ and of CD28null T cells of DS 
and control patients in CD4 and CD8 subset of lymphocytes. Expression of late activation marker 
(CD25), early activation marker (CD69) and chemokine RANTES receptor CCR5 in CD4 and CD8 
subsets and prevalence of CD4+ CD28null and CD8+CD28null cells were studied in peripheral blood 
by flow cytometry. Data are presented as % of cells expressing individual marker. Results presented 
as median (Q1; Q2). * - p = 0,0076; ** - p = 0,0006. (b) Presence of CD25high (h) T cells in DS and 
control patients. Results presented as median (Q1; Q2). * - p = 0,0012. (c) Example of flow 
cytometric results for CD25high CD4+ T cell subsets for DS (upper right) and control (upper left) 
groups. CD25+ gate was placed on the basis of isotype control staining (lower left). 
Figure 4. (a) Results of intracellular staining of CD4+ and CD8+ T cell subsets in peripheral blood of 
DS and control patients. Percentage of cells producing IL-4, IL-17, TNFα or IFNγ was assessed by flow 
cytometry. Results presented as median (Q1; Q2). (b) Example of flow cytometric results and gating 
strategy of intracellular staining for CD4+ (left) and CD8+ (right) T cell subsets. 
Figure 5. (a) Comparison of monocytes and monocyte subsets in peripheral blood of DS and control 
patients. Counts of the presented subpopulations were assessed by flow cytometry. Results 
presented as median (Q1; Q2); n control group = 24, n DS = 19. (b) Example of flow cytometric 
gating strategy of monocytes and their subpopulations. Gating of monocytes and their subsets: M2 - 
gate applied to exclude CD14-HLA-DR- cells, M3 - CD14highCD16-, M4 - CD14highCD16+, M5 - 
CD14dimCD16+. 
